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ABSTRACT 
Bunyaviruses are considered to be emerging 
pathogens facilitated by the segmented nature 
of their genome that allows reassortment 
between different species to generate novel 
viruses with altered pathogenicity. 
Bunyaviruses are transmitted via a diverse 
range of arthropod vectors, as well as rodents, 
and have established a global disease range 
with massive importance in healthcare, animal 
welfare and economics. There are no vaccines 
or anti-viral therapies available to treat human 
bunyavirus infections and so development of 
new anti-viral strategies is urgently required. 
Bunyamwera virus (BUNV; genus 
Orthobunyavirus) is the model bunyavirus, 
sharing aspects of its molecular and cellular 
biology with all Bunyaviridae family 
members. Here, we show for the first time that 
BUNV activates and requires cellular 
potassium (K
+
) channels to infect cells. Time 
of addition assays using K
+
 channel 
modulating agents demonstrated that K
+
 
channel function is critical to events shortly 
after virus entry but prior to viral RNA 
synthesis/replication. A similar K
+
 channel 
dependence was identified for other 
bunyaviruses namely Schmallenberg virus 
(Orthobunyavirus) as well as the more 
distantly related Hazara virus (Nairovirus). 
Using a rational pharmacological screening 
regimen, twin-pore domain K
+
 channels (K2P) 
were identified as the K
+
 channel family 
mediating BUNV K
+
 channel dependence. As 
several K2P channel modulators are currently 
in clinical use, our work suggests they may 
represent a new and safe drug class for the 
treatment of potentially lethal bunyavirus 
disease.   
 
INTRODUCTION 
The Bunyaviridae family represents the largest 
taxonomic grouping of negative sense RNA- 
viruses, with over 350 named members (1). 
The family is divided into five genera, 
Orthobunyavirus, Hantavirus, Tospovirus, 
Phlebovirus and Nairovirus and takes its name 
from Bunyamwera virus (BUNV), the 
prototype of the genus Orthobunyavirus.  
All bunyaviruses share common 
elements of virion structure being enveloped 
and containing an RNA genome that 
comprises three separate RNA segments 
named small (S) medium (M) and large (L). 
These three segments encode four structural 
proteins using an expression strategy that is 
conserved across all members of the family: 
the S segment encodes the nucleoprotein (N), 
the M segment encodes two glycoproteins (Gn 
and Gc), and the L segment encodes an RNA-
dependent RNA polymerase (L protein). Most 
Bunyaviridae family members including 
BUNV also encode two non-structural 
proteins; NSs from the S segment, and NSm 
from the M segment (2,3). 
Bunyaviruses are predominantly 
arthropod-borne viruses capable of infecting a 
wide range of hosts including humans, plants 
and animals. Four of the five bunyavirus 
genera include members that are associated 
with lethal haemorrhagic fevers in infected 
humans, and many are considered to be 
emerging pathogens due to a complex 
combination of factors including travel, animal 
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trade, and climate change (4-6). Bunyavirus 
emergence is facilitated by the segmented 
nature of their genome that allows 
reassortment between different species to 
generate novel viruses with altered 
pathogenicity (7). Schmallenberg (SBV) and 
Ngari (NGAV) viruses are orthobunyaviruses 
that exemplify this phenomenon; NGAV, 
which causes a highly fatal haemorrhagic fever 
in humans (8) is a reassortant possessing S and 
L segments from BUNV and the M segment 
from the closely related Batai virus (BATV) 
(9). Similarly, SBV, which is a pathogen 
responsible for teratogenic disease in sheep 
and cattle (10), has a complex genetic 
background possessing segments shared with 
previously characterised Sathuperi and 
Shamonda viruses (11). The threat of 
widespread arthropod borne transmission of 
these potentially lethal emerging viruses 
means the development of preventative and 
therapeutic strategies is urgently required. 
One strategy to identify new anti-viral 
therapies is to target virus host interactions 
that are essential for virus multiplication. 
Many examples of such interactions have been 
described for bunyaviruses (reviewed in 
(12,13)) and other recent examples include 
those involved in virus entry (14), 
counteracting the antiviral response (15-17) 
and modulating host gene expression (16,18). 
Another group of potential targets are host cell 
ion channels, which regulate ion homeostasis 
across all cellular membranes and are key 
players in a broad and extensive range of 
cellular processes including the cell cycle, 
gene expression, cell signalling and innate 
immunity (19-21). Ion channels are emerging 
as key factors required during virus replicative 
cycles, and have been assigned critical roles in 
virus entry, survival and release. Examples 
include roles for both potassium (K
+
) and 
chloride ion (Cl
-
) channels during the hepatitis 
C virus lifecycle (22,23), the ability of human 
immunodeficiency virus proteins to modulate 
K
+
 channel activity (24,25)  and the recently 
identified requirement of two-pore calcium 
(Ca
2+
) channels (TPCs) in endosomal 
membranes for successful entry of Ebola virus 
(26). Here, we report that BUNV 
multiplication depends on the function of 
cellular K
+
 channels. Using the available ion 
channel pharmacological tools, a small family 
of twin pore potassium ion channels (K2P) was 
identified as the candidate K
+
 channel family 
critical for BUNV multiplication. We propose 
that targeting K
+
 channel function may 
represent a new, pharmacologically safe and 
broad ranging therapeutic strategy for this 
important family of pathogens. 
 
EXPERIMENTAL PROCEDURES 
Cells and viruses - A549 (adenocarcinomic 
human alveolar basal epithelial cells) and Vero 
(African green monkey kidney cell lines) cells 
were obtained from the European Collection of 
Cell Cultures (ECACC) and maintained at 
37°C in Dulbecco's modified Eagle's medium 
(DMEM- Sigma) supplemented with 10% fetal 
bovine serum (FBS), 100 U/mL penicillin and 
100 μg/mL streptomycin. Huh7 cells 
(hepatocyte derived cellular carcinoma cell 
line) were a gift from R. Bartenschlager 
(Heidelberg University) and maintained under 
these conditions but additionally supplemented 
with non-essential amino acids. BSRT-7 cells 
(derived from BHK21 cells, that constitutively 
express bacteriophage T7 polymerase) were 
obtained from K. K. Conzelmann (University 
of Munich) (27) and maintained under these 
conditions but additionally supplemented with 
G418 (100µg/ml). U87-MG cells (a human 
glioblastoma-astrocytoma, epithelial-like cell 
line) were obtained from the ECACC and 
grown in minimal essential Eagle’s medium 
(MEM) supplemented with 10% FBS, 1mM 
sodium pyruvate, 1mM non-essential amino 
acids, 2mM L-glutamine, penicillin G 
(100U/ml) and streptomycin (100μg/ml). All 
mammalian cells were incubated in a 
humidified incubator at 37°C in the presence 
of 5% CO2. Ae. albopictus C6/36 cells (a gift 
from L. Alphey, University of Oxford) were 
grown at 28°C in Leibovitz’s 15 medium 
(Sigma) supplemented with 10% FBS and 
10% tryptose phosphate broth. Working stocks 
of wild-type BUNV (provided by R. Elliot, 
Glasgow Centre for Virus Research) was 
prepared as described previously (28). HAZV 
(strain JC280, ECACC) was propagated in 
SW13 cells (human adrenal cortex carcinoma 
cell line, ECACC) and clarified supernatants 
were used to infect A549 cells. The titre of 
infectious HAZV was estimated by plaque 
assay; typical yields from virus propagation 
experiments were between 1x 10
5
 and 1x10
7
 
plaque forming units per mL (pfu/mL). Human 
RSV strain A2 (subgroup A, ECACC) was 
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passaged through HEp-2 cells (human cervix 
carcinoma cell line, ECACC) and purified by 
sucrose density gradient according to 
previously described protocols. (29).  Viral 
titres were accurately determined in HEp-2 
cells by a modified methylcellulose-based 
plaque assay with immunostaining using goat 
anti-hRSV antibodies (Abcam). SBV (strain 
BH80/11-4 provided by M. Beer, Friedrich-
Loeffler Institute) was propagated in Vero 
cells in the presence of 2% FBS. 
Drug treatments - For the assessment 
of BUNV infection, 1x10
5
 cells/well were 
seeded into 6 well plates and allowed 24 h to 
settle. Where indicated, cells were pre-
incubated with the specific ion channel 
modulator for 45 minutes, or media 
supplemented with the solvent control of each 
channel modulator, prior to and during virus 
infection. Cells were infected at an MOI of 1 
for 24 hours.  
Assessment of virus production by 
western blot analysis - BUNV-N protein 
expression was assessed using the following 
method. Infected cells were lysed in GLB 
buffer (25mM glycerol phosphate, 20mM Tris, 
150 mM NaCl, 1mM EDTA, 1% Triton X-
100, 10% glycerol, 50mM NaF) plus protease 
inhibitors (Complete; Roche). Cell lysates (50 
μg protein) were normalized by BCA assay 
and resolved by SDS-PAGE, transferred to a 
PVDF membrane (Millipore) using a Bio-Rad 
Laboratories semidry transfer apparatus, and 
probed with a sheep BUNV-N serum followed 
by labelling with anti-sheep HRP conjugated 
secondary antibodies (Sigma). All Western 
blots were visualized using ECL system 
(Advansta). HAZV-N expression was assessed 
using a sheep HAZV-N serum before labelling 
with anti-sheep HRP conjugated secondary 
antibodies (Sigma). For HRSV staining, cells 
were labelled with goat anti-hRSV antibodies 
(Abcam) and anti-goat HRP conjugated 
secondary antibodies (Pierce). 
Immunofluorescent analysis – For the 
assessment of BUNV infection, infected cells 
grown on polylysine coated glass coverslips 
were fixed with methanol for 10 min, 
permeabilized in ice-cold methanol/acetone for 
10 min, and blocked in PBS/1% BSA for 30 
min. For BUNV-N protein staining, cells were 
labelled with sheep anti-BUNV-N serum 
before staining with sheep Alexa Fluor 594 nm 
conjugated anti-sheep secondary antibodies 
(Invitrogen-Molecular Probes) in PBS/1% 
BSA. Cells were washed and mounted onto 
microscope slides using prolong gold 
containing DAPI (Invitrogen-Molecular 
Probes). Labeled cells were viewed on an 
inverted Zeiss 510-META laser-scanning 
confocal microscope under an oil-immersion 
40 or 63× objective lens (NA = 1.40). Alexa 
Fluor 594 nm (550 nm excitation, 570 nm 
emission) was excited using a helium/neon 
laser fitted with 543 nm filters. Displayed 
images are representative of at least three 
independent experiments and displayed as 
single optical sections of 50 μm thickness. 
Randomly chosen fields were observed under 
fluorescence microscopy to assess virus 
staining and the number of virus positive cells 
quantitated for ≥100 cells per condition using 
ImageJ software as previously described (30). 
Results are presented as means ± SEM from a 
minimum of three independent experiments. 
For HAZV-N staining, cells were labelled with 
sheep anti-HAZV-N serum before staining 
with sheep Alexa Fluor 594 nm conjugated 
anti-sheep secondary antibodies. For hRSV 
staining cells were labelled with goat anti-
hRSV antibodies (Abcam) and stained with 
goat Alexa Fluor 594 antibodies (Invitrogen-
Molecular Probes). For the assessment of 
endogenous K2P channel expression, fixed 
A549 cells were labelled with anti-KCNK 1, 2, 
7 or 9 antibodies (Santa Cruz Biotechnology 
Inc) and stained with the appropriate Alexa 
Fluor 488/594 antibodies (Invitrogen-
Molecular Probes). 
Time-course assays - BUNV infected 
cells were treated with TEA (10 mM) or 
quinidine (200µM) in the media during the 24 
h infection period (T=0), or added 1, 2, 4, 6, 8 
and 10 hpi. Virus infection was allowed to 
proceed for a total of 24h, and cells were lysed 
for western blot analysis. For the assessment 
of BUNV entry, A549 cells were treated 
during the initial 1h of BUNV infection with 
TEA (10 mM) or monensin (20 µM). BUNV 
virions that were not internalised were washed 
off with 0.5% trypsin in PBS (x3). Media was 
then replaced and the cells incubated for 24 h 
before analysis.  
BUNV growth assays - BUNV was 
propagated in Vero cells in DMEM containing 
2% FBS. Culture supernatants were harvested 
when >90% cytopathic effect (CPE) was 
observed and passed through a 0.45 µm 
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syringe filter to removed cellular debris. For 
virus inhibition experiments, growth medium 
was removed from Vero cells and replaced 
with 2% FBS DMEM, supplemented with the 
appropriate drug dilution, for 1 h at 37°C. 
Medium was transferred to empty plates while 
cells were incubated for 1 h at 37°C with 
serum-free medium (Mock) or serum-free 
medium containing 500 TCID50/ml BUNV 
(MOI ~ 0.025). Medium was discarded and 
drug containing-medium was returned and 
cells incubated for 5 days. Cells were washed 
and fixed in 100% ethanol for 30 minutes at 
room temperature before staining with 3% 
(w/v) crystal violet for 1 hour at room 
temperature.  
BUNV transcription/replication - 
A549 cells were infected with BUNV (MOI 1) 
and either treated with TEA (10 mM), or left 
untreated. At 1, 6 or 24 hpi, total cell RNA 
were harvested using an RNeasy kit (Qiagen). 
RNA from mock infected A549 cells was also 
harvested. All RNAs were subjected to primer 
extension analysis as previously described 
(31), using 
33
P end labelled oligonucleotide 
primer P-ext (5’ 
GAGCCTTTAATGACCTTCTGTTGG 3’) 
designed to anneal to nucleotides 58 - 81 of 
the BUNV S segment anti-genome. Extension 
products were separated by 6% denaturing 
PAGE, and visualized using autoradiography. 
BUNV replicon assays were performed as 
previously described (12,31). Briefly, BSRT7 
cells were transfected with cDNA plasmids 
encoding BUNV S and L segment open 
reading frames (ORFs), and a model negative 
sense RNA segment that contained conserved 
BUNV 3’- and 5’- non-translated regions 
flanking the Renilla luciferase ORF. Cells 
were incubated with or without TEA (5 or 
10mM) for 18 h and lysed in passive lysis 
buffer (Roche). Cell lysates were analysed for 
luciferase activity (relative luminescence units 
[RLU] per second) as a measure of BUNV 
gene expression. The L ORF plasmid was 
omitted and replaced with GFP to act as a 
negative control to measure non-BUNV 
mediated luciferase expression. Results were 
normalised to those for an untreated control. 
Error bars represent the standard errors of the 
means (SEM) of results from three 
independent experiments performed in 
duplicate.  
Resting membrane potential assay - 
Cells were treated with 20 µM DiBAC4(3) 
(Sigma) in media for 20 mins at 37ºC and 
protected from light. Conditions were selected 
as optimal from standardisation of DiBAC4(3) 
concentrations, incubation time and 
temperature. Following labelling, cells were 
washed and either mock-infected or infected 
with BUNV (MOI 1). Cells were treated with 
TEA (10 mM) or quinidine (200µM) as 
controls. The average mean intensity of green 
fluorescence GCU (Green Calibration Units 
per cell) was measured from several widefield 
images using IncuCyte ZOOM live cell 
imaging at 1 h intervals for up to 6 h. Values 
are presented as the mean fluorescent intensity 
per cell normalized to untreated controls from 
a minimum of three independent experiments. 
Assays of [Cl
-
]i using 5 mM 6-methoxy-
quinolyl acetoethyl ester (MQAE) were 
performed as previously described (22). 5-
nitro-1-3-phenylpropylamino benzoic acid 
(NPPB) and indyanyloxyacetic acid 94 (IAA-
94) were included as compounds known to 
modulate Cl
-
 function for assay verification.  
K2P Channel RT-PCR - Total cell 
RNA was extracted from A549 cells and 
reverse transcribed under the following 
conditions: 3 min 94ºC; 30 cycles, 45 sec  
94ºC, 30 sec 55ºC and 90 sec 72ºC; final 
extension 10 min 72ºC. Primers for KCNK1-
17 are available on request. PCR products 
were resolved on 2% agarose gels.  
Statistical analyses- The statistical 
significance of data was determined by 
performing a student t-test or one way 
ANOVA test. Significance was deemed when 
the values were less than or equal to the 0.05 P 
value. 
 
RESULTS 
K
+
 channels are required for BUNV 
infection - To determine if the activity of host 
cell K
+
 channels are required during the 
bunyavirus lifecycle, BUNV infection assays 
were performed in the presence of broad-
spectrum K
+
 channel modulators used at 
pharmacologically relevant concentrations. 
BUNV growth was assessed through detecting 
the expression of the BUNV nucleoprotein 
(BUNV-N); known to correlate with virus 
production (28). Tetraethylammonium (TEA), 
a broad spectrum K
+
 channel blocker, inhibited 
BUNV infection at concentrations ≥2 mM 
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(Figure 1A-B). A similar effect was seen when 
extracellular KCl was increased above 20 mM 
(Figure 1A-B) to collapse K
+
 gradients and 
inhibit K
+
 channel activity. Any non-K
+
 
channel effects due to the off target effects of 
these compounds were ruled out as a second 
K
+
 salt K2S04 similarly inhibited BUNV-N 
production at concentrations ≥ 20mM (32-37). 
These data were confirmed when the 
percentage of BUNV infected cells was 
assessed by analysis of immunofluorescence 
staining for BUNV-N (TEA = 73.85%± 15.3 
reduction P≤ 0.05, KCl = 82.32%± 13.2 
reduction P≤ 0.05, K2S04 = 94.20%± 5.0 
reduction P≤ 0.05), (Figure 1B-C grey bars). 
At the concentrations assessed all compounds 
were non-toxic as confirmed by ATPlite
TM
 
viability assays (Figure 1D (ii) black bars). To 
further confirm the findings, the effects of K
+
 
channel inhibition were assessed on the 
accumulated RNA products of either BUNV 
mRNA transcription or genome replication 
using primer extension (Figure 1E). At the 24 
h time point, extension products corresponding 
to BUNV mRNA transcripts and BUNV anti-
genomic RNAs were detectable in BUNV-
infected cells. In contrast, extension products 
were undetectable in BUNV-infected cells 
treated with TEA (Figure 1E, compare lanes 4 
& 7). Taken together, these data indicate a 
specific requirement for K
+
 channel function 
during the BUNV replicative cycle.  
K
+
 channel dependence is conserved 
across invertebrate and vertebrate cell types - 
As expected from its arthropod-borne 
transmission to a variety of mammalian hosts, 
BUNV can replicate in a range of vertebrate 
and invertebrate cell lines (3,4). The 
dependence of BUNV on K
+
 channel function 
was therefore assessed in a range of cell types. 
Vero (monkey kidney cells) U87-MG (human 
glioblastoma cells), Huh7 (human 
hepatocellular carcinoma cells) supported 
BUNV infection, as evidenced by robust 
BUNV-N expression (Figure 2A), which was 
inhibited by the addition of TEA and KCl. To 
rule out the possibility of the observed 
inhibition being restricted to BUNV-N 
expression, the effects of K
+
 channel inhibition 
on virus infection and spread was assessed. 
BUNV induces extensive cytopathic effect 
(CPE) in Vero cells resulting in the formation 
of plaques under solid culture or the 
destruction of the monolayer under liquid 
culture. In untreated Vero cells infected with 
BUNV at a low MOI (~ 0.025), the cytopathic 
effect (CPE) was so extensive after 5 days of 
culture that no cell monolayer was present to 
take up stain (Figure 2B). In contrast, 
treatment of BUNV-infected cells with 
≥30mM KCl abrogated virus-induced CPE, 
confirming that K
+
 channel modulation 
inhibits BUNV production. Numerous K
+
 
channels are expressed in insect cells (38,39). 
Indeed Drosophila ATP-sensitive K
+
 channels 
have been demonstrated to mediate resistance 
to a cardiotropic RNA virus, flock house virus 
(40). The effects of K
+
 inhibition on BUNV 
infection were therefore assessed in C6/36 (Ae. 
albopictus cells) as a representative cell line 
for the BUNV arthropod host (41). BUNV-N 
production was highly sensitive to K
+
 channel 
blockade as TEA ≥2 mM and KCl ≥20 mM 
inhibited BUNV-N production to almost 
undetectable levels (Figure 2C). These data 
confirmed that BUNV infection of both 
mammalian and mosquito cells is similarly 
inhibited by K
+
 channel modulation. 
K
+
 channel dependence is bunyavirus 
specific- The diversity within bunyaviruses is 
revealed by their division into five distinct 
genera. In order to assess whether growth of 
other bunyaviruses exhibited similar 
dependence on K
+ 
channel activity, Hazara 
virus (HAZV); a member of the Nairovirus 
genus, and a close relative of the highly 
pathogenic hazard group 4 virus Crimean 
Congo haemorrhagic fever virus (CCHFV; 
(42)) was assessed. HAZV was similarly 
inhibited in the presence of TEA ≥ 2 mM, as 
judged by a clear decrease in the abundance of 
HAZV-N protein and the reduction of the 
number of HAZV infected cells treated with 
TEA, (Figure 3A, 59.97% reduction ± 20.37 
P≤ 0.05). Production of the orthobunyavirus 
SBV was also sensitive to K
+
 channel 
inhibition through KCl treatment. Treatment of 
SBV-infected Vero cells with ≥30mM KCl 
abrogated SBV-induced CPE in a manner 
identical to BUNV (Figure 3B). To investigate 
if K
+
 channel sensitivity occurs during the 
replicative cycle of other unrelated negative 
sense RNA virus families, human respiratory 
syncytial virus (hRSV), a non-segmented RNA 
virus of the family Paramyxoviridae was 
assessed under identical conditions of TEA 
treatment. Unlike ribavirin, which was 
strongly inhibitory to hRSV production as 
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expected from previous work (43), A549 cells 
treated with TEA concentrations of 5 or 10 
mM could support hRSV infection as 
evidenced by hRSV protein production and the 
comparable numbers of hRSV infected cells 
compared to no-drug controls, (Figure 3C, P≥ 
0.05). The fact that hRSV infection levels 
were identical to untreated controls in the face 
of K
+
 modulation ruled out any effects of K
+
 
channel inhibition on general cell/virus 
metabolic processes. Similarly we have 
previously reported that both TEA and KCl do 
not impact Hepatitis C virus replication at 
these concentrations in Huh7 cells, which were 
permissive to BUNV infection (Figure 2), 
(22). Taken together, these data indicate a 
specific process during the bunyavirus 
lifecycle is impeded by K
+ 
channel inhibition.  
K
+
 channel function is required at an 
early stage of BUNV infection - The stage of 
the BUNV lifecycle that requires K
+
 channel 
activity was next investigated. To assess the 
earliest events of virus infection, A549 cells 
were incubated with BUNV in the presence of 
TEA (10 mM) for 1 h at 37°C. Virus/drug was 
then removed and the cells incubated for a 
further 24 h to allow infection to proceed 
(Figure 4A i) and ii) respectively). Monensin 
(20µM), an inhibitor of clathrin-mediated 
endocytosis (CME), was included in the 1 h 
treatment as a positive control (44). Under 
these conditions, TEA had no impact on 
BUNV attachment/entry compared to the 
untreated cells (Figure 4A (i) lanes 2 and 3, P≥ 
0.05). In contrast, CME inhibition with 
monensin significantly impeded BUNV entry 
(Figure 4A (i-ii), 60.27% ± 20.23 reduction in 
BUNV-N, P≤ 0.05). This strongly suggested 
that K
+
 channel inhibition does not inhibit 
BUNV infection at the stage of virus entry. To 
observe later lifecycle events, time-of-addition 
experiments were performed. Cells were 
infected for 60 min and washed, and 
incubation continued at 37°C for 24 h in the 
presence of TEA added at defined timepoints 
post-infection.  When TEA was added 1-2 
hours post infection (hpi), BUNV-N 
expression was not detected (Figure 4B, 
compare lanes 1 and 2-4). BUNV-N 
expression began to recover when treatment 
was delayed to 4 hpi, and was unaffected when 
treatment was initiated at 6 hpi. Thus, BUNV 
replication is restricted by synchronous or 
early treatment with K
+
 channel blockers (≤ 4 
hpi) but not by treatment at later timepoints 
when virus gene expression has been initiated 
(≥ 6 hpi). From the observed kinetics of virus 
inhibition it was not clear whether the virus 
was inhibited at a stage of entry/uncoating or 
the initial steps of virus replication. The effects 
of TEA on BUNV-specific mRNA 
transcription and RNA replication (events that 
take place following uncoating of BUNV in 
the cytoplasm and subsequent release of the 
ribonucleoprotein (RNP) particles) were 
assessed using artificial BUNV minigenome 
assays, containing Renilla luciferase as a 
reporter (45). This approach allowed the 
assessment of BUNV-specific RNA synthesis 
independently from virus entry stages, as all 
components of the replicon assay are delivered 
by plasmid transfection, thus circumventing 
initial stages of the BUNV lifecycle. TEA did 
not affect these processes with similar levels 
of BUNV transcription observed between 
untreated vs TEA (5 or 10mM) treated cells 
(Figure 4D, P≥ 0.05). This confirmed that the 
K
+
 channel-dependent effect during BUNV 
infection occurs at a post-entry stage that is 
prior to viral RNA synthesis.  
BUNV enhances cellular K
+
 channel 
activity - As BUNV is dependent on K
+
 
channel activity during the early stages of the 
virus lifecycle, its ability to modulate the 
functionality of these channels was assessed. 
K
+
 channels play a crucial role in setting the 
resting membrane potential (the charge 
difference across the cell membrane). The 
membrane potential can either become more 
negative (hyperpolarization) or more positive 
(depolarization) compared with the resting 
potential as various ion channels open. In 
general, the activation of K
+
 channels would 
be expected to cause hyperpolarization that 
can be monitored using a membrane potential-
sensitive dye, bis (1, 3-dibutylbarbituric acid) 
trimethine oxonol; DiBAC4(3)) (46). Influx of 
DiBAC4(3) and an increase in fluorescence 
indicates cell depolarisation, whilst 
hyperpolarization is indicated by a decrease in 
fluorescence intensity (47). Potential-
dependent fluorescence changes generated by 
DiBAC4(3) are typically ~1% per mV (46). 
A549 cells infected with BUNV exhibited a 
hyperpolarised resting membrane potential 6 
hpi compared to uninfected cells, as indicated 
by the decrease in DiBAC4(3) fluorescent 
intensity (Figure 5A, -16.23mV ± 0.14 shift). 
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Such a change is consistent with enhanced K
+
 
channel activity during the early stages of 
BUNV infection. To validate the assay, TEA 
(10mM) and quinidine (200µM) were included 
during membrane potential measurements and 
led to depolarisation as would be expected to 
occur in the face of K
+
 channel blockade 
(Figure 5A). Importantly, these effects were 
reproducible in C6/36 cells where BUNV 
infection led to a significant reduction in 
DiBAC4(3) fluorescence 6 hpi (Figure 5A, -
18.3mV ± 1.5mV shift in BUNV cells).  To 
confirm these shifts were K
+
 channel specific, 
we examined Cl
−
 homeostasis during BUNV 
infection using the fluorescent indicator N-
ethoxycarbonylmethyl-6-methoxy-quinolinium 
bromide (MQAE), a dye quenched by 
enhanced Cl
−
 influx and the subsequent 
increase in intracellular chloride concentration 
[Cl
−
]i. Figure 5B demonstrates that BUNV did 
not affect [Cl
−
]i compared to uninfected A549 
cells (p≤0.05), consistent with no effects on 
basally active Cl
− 
conductance. MQAE 
fluorescence was reduced by treatment with 
NPPB and IAA-94 (known Cl
-
 channel 
modulators). Taken together, these data 
provide evidence that BUNV specifically 
alters the functionality of K
+
 channels during 
early stages of the virus replicative cycle to 
regulate cellular K
+
 flux in both vertebrate and 
invertebrate cell lines. 
Investigating the K
+
 channel families 
required during BUNV infection - Having 
determined that BUNV cannot establish a 
productive infection in the face of K
+
 channel 
blockade, the molecular identity of the specific 
K
+
 channel(s) required during the BUNV 
lifecycle were investigated. Over 70 different 
genes encode K
+
 channel subunits in the 
human genome, which are divided into 
subfamilies of voltage-gated K
+
 channels (Kv), 
calcium-activated K
+
 channels (BK), inwardly 
rectifying K
+
 channels (Kir) and two-pore K
+
 
channels (K2p) channels (48). Quinidine and 
quinine block specific members of all of these 
subfamilies (Figure 6A) and significantly 
inhibited BUNV-N production and reduced the 
number of BUNV infected cells (quinidine 
~66.2% ± 25.7, quinine ~79.8% ± 17.0 
reduction in BUNV infected cells, compared 
to untreated controls (Figure 6B-D, p≤0.05). 4-
aminopyridine (4AP), an inhibitor of Kv 
channels (49), and barium chloride (BaCl2), an 
inhibitor of Kir channels (50,51), did not 
impede BUNV infection suggesting that 
neither Kv nor Kir activity is required during 
the BUNV lifecycle (Figure 6A-D, p≥0.05). 
Consistent with these findings, cells were 
protected from BUNV-induced CPE in a 
concentration dependent manner by both 
quinine and quinidine, but virus growth was 
unaffected in the presence of either 4AP or 
BaCl2 (Figure 6E). Similarly SBV growth was 
strongly inhibited by quinine and quinidine 
treatment but was unaffected by 4AP or BaCl2 
(data not shown). Modulation of Ca
2+
 activated 
K
+ 
channels (Tram 34), ATP sensitive K
+
 
channels (Glibenclamide) and G-protein 
coupled Kir channels (Ifenprodil) also did not 
influence BUNV-N production suggesting 
these K
+
 channel family members do not 
contribute to BUNV growth (Figure 6 A-D). 
Time-of-addition experiments for quinidine 
(Figure 6F) additionally confirmed the drug 
inhibits BUNV at an identical stage to that 
observed for TEA (Figure 5C); quinidine 
inhibited BUNV-N production when 
administered at 0 to 4 hpi and a recovery of 
BUNV-N production occurred when 
administered ≥ 6 hpi (Figure 6F, compare 
lanes 1, 6-8). Taken together, these data 
suggest that BUNV requires the function of 
quinine- and quinidine sensitive host cell K
+
 
channel(s) that are unlikely to be members of 
the Kv, BK and Kir families. Given the lack of 
effect of Kv, BK and Kir modulation on 
BUNV infection, the role of the K2P channel 
superfamily during the BUNV lifecycle were 
investigated (52-54). In mammals, seventeen 
K2P channel genes have been identified and the 
expression of 12 of these members (KCNK 1-
7, 9, 10, 13, 15, & 17) were detected in A549 
cells by RT-PCR analysis confirming their 
potential involvement in the BUNV lifecycle 
(Figure 7A(i)). Protein expression was further 
confirmed for KCNK1, KCNK2 ,KCNK7 & 
KCNK9 by immunofluorescent staining 
(Figure 7A(ii)). K2P channels are distinguished 
by the presence of two K
+
 pores arranged in 
tandem, sensitivity to quinine and quinidine, 
and a relatively poorly defined pharmacology 
compared to other K
+
 family members 
(52,55,56). However, certain organic 
compounds have proven useful to indicate 
physiological roles of many K2P family 
members (Figure 7B). The organic polycations 
ruthenium red (RuR) and spermine can 
directly block specific K2P channels through 
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the interaction with negatively-charged 
residues in the K2P pore domains (52,57). Both 
compounds inhibited BUNV-N production in a 
concentration-dependent manner (Figure 7C) 
and significantly reduced the percentage of 
BUNV infected cells (RuR (50µM) ~82.1% ± 
15.21 reduction, spermine (500µM) ~88.5% ± 
16.61 reduction, p≤0.05), compared to 
untreated controls (Figure 7D (i-ii) grey bars) 
with no cytotoxicity at the highest 
concentration used (Figure 7D (ii) black bars). 
In addition, drugs approved by the U.S. Food 
and Drug Administration (FDA), including 
bupivacaine (local anaesthetic), haloperidol 
(antipyschotic) and fluoxetine (anti-
depressant), similarly inhibited BUNV-N 
production and reduced the percentage of 
BUNV infected cells at concentrations 
reported as inhibitory to K2P channels 
(bupivacaine (150µM) ~76.8%± 27.9, 
haloperidol (20µM) ~76.3% ± 22.4 inhibition, 
fluoxetine (30µM) ~87.2%± 8.9 inhibition), 
(Fig 7C-D, p≤0.05) (52,56,58). We 
additionally observed inhibition of BUNV by 
curcumin and genistein, both of which are 
known blockers of K2P members (data not 
shown). These findings implicate K2P channels 
as the K
+
 channel family member required by 
BUNV during the early stages of virus 
infection.  
DISCUSSION 
Ion channels underpin an array of essential 
cellular processes and drugs acting on specific 
ion channels are the treatment of choice for 
many diseases (48). Using the available 
pharmacological tools targeting various 
cellular ion channels, this study showed that 
K
+
 channel function is critical to the growth of 
BUNV (Figures 1-2), the prototypic 
bunyavirus in both vertebrate and invertebrate 
cells. K
+
 channel dependence was also 
observed with HAZV and SBV, revealing this 
as a key virus-host interaction across other 
bunyaviruses (Figure 3), suggesting it may be 
a general property that applies to all family 
members. 
It is not clear why the BUNV 
replicative cycle is dependent upon 
manipulation of host cell K
+ 
channel currents. 
Previous reliance of bunyavirus replication 
had been noted by Frugulhetti and Rebello 
(59), who reported that changes in K
+
 ion 
concentrations disrupted the growth of the 
orthobunyavirus Marituba virus. The stage of 
the life cycle affected was found to be mRNA 
translation, although the mechanism that 
underpinned this dependence was not pursued, 
and the role of cellular ion channels in this 
process was not investigated. In the present 
study, K
+
 channel modulation had no 
discernible effect on mRNA transcription and 
translation in the context of the BUNV 
minireplicon system (Figure 4C) and so we 
suggest that our findings of K
+
 channel 
reliance are likely unrelated to these early 
findings. To better understand the nature of the 
K
+
 channel requirement, time of addition 
assays were performed which indicated that 
the K
+
 sensitive steps in the BUNV life cycle 
occur within the initial 6 hours of virus 
infection, but do not include virus 
binding/entry (Figure 4A & B). It is thus most 
likely that K
+
 channel modulation contributes 
to early events within the virus life cycle 
including virus uncoating and/or events prior 
to the formation of RNA replication factories, 
postulated to assemble around the Golgi (60-
62).  
A key finding of this study is that K2P channels 
are the K
+ 
family member required for BUNV 
infection. BUNV was inhibited by diverse 
pharmacological agents that modulate K2P 
channels (52,57,58,63,64), but no effects of K
+
 
channel modulators targeting Kv, BK, and Kir 
channels was observed. The family of K2P 
channels is small containing only ~17 
members, which regulate the membrane 
potential of both “excitable” and “non-
excitable” cells (58). K2P channels respond to a 
diverse array of stimuli including pH, 
temperature and membrane stretch and their 
pharmacology is highly characteristic, as a 
result of their distinct structural features 
(55,56,65). Using a fluorescent membrane 
potential probe, hyperpolarisation of the 
plasma membrane was observed in BUNV 
infected cells 6 hpi (Figure 4), a shift 
consistent with an enhancement of K2P activity 
at the stage of the virus lifecycle sensitive to 
K
+
 channel modulation. Many viruses encode 
their own viroporin (reviewed in (66)) which 
are pore forming proteins that have been 
documented to participate in several viral 
functions, including the promotion of release 
of virus particles, modulation of cellular 
vesicles, glycoprotein trafficking and 
membrane permeability. As BUNV has no 
known viroporin, it is possible that BUNV 
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proteins have evolved to interfere and depend 
on cellular K2P channels to aid virus 
pathogenesis. Whilst we do not understand the 
mechanism(s) of K2P activation, our findings 
implicate BUNV structural proteins present in 
the virion to mediate these effects since viral 
gene expression would not have occurred at 
these timepoints, and thus no new proteins 
would be generated. Orthobunyaviruses have 
been shown to enter cells via clathrin mediated 
endocytosis (44), but events post-entry are less 
well understood, although virion trafficking of 
CCHFV has been shown to be ESCRT 
dependent (67). The modulation/reliance upon 
host cell ion K2P channels at this post-entry 
stage is consistent with recent observations for 
other negative sense enveloped viruses. Post-
entry trafficking of Ebola virus, a single 
stranded negative sense RNA virus, is 
dependent upon endosomal calcium channels 
termed two-pore channels (TPCs) (26). In 
addition the capsid (C) protein of dengue 
virus, a single stranded positive sense RNA 
virus, forms an association with lipid 
membranes that is intrinsically dependent on 
the intracellular concentrations of K
+
 ions (68). 
The cellular mechanisms of these ion-channel 
dependent events remain to be elucidated 
As HAZV represents a model for 
CCHFV (41), a cause of a severe, often fatal 
disease in humans, this study highlights the 
potential of K
+
 channel modulating drugs as a 
novel therapeutic intervention against more 
dangerous pathogens of this family.  It is 
interesting to note that compounds such as 
haloperidol and fluoxetine possess highly 
desirable drug properties in a clinical setting; 
good oral bioavailability (60-70%), generally 
well tolerated with severe side effects 
uncommon and the ability to cross the blood 
brain barrier (63,69). This may be pertinent for 
bunyavirus treatment since BUNV infection in 
both mouse and horses is largely neurotropic 
(70,71). Indeed BUNV infection was 
permissive in U87-MG cells; a human 
primary glioblastoma cell line, and could be 
inhibited by K
+
 channel modulation (Figure 2).  
In conclusion, despite encompassing a 
large number of viruses capable of causing 
outbreaks that would impact public health, 
national economies and food security; little is 
known regarding key stages in the life cycle of 
bunyaviruses. This study has demonstrated the 
importance of K
+
 channel activity during the 
BUNV lifecycle and contributes to the 
growing field of viral ion channel interactions. 
Targeting these K
+
 channels in patients 
infected with severe Bunyaviridae infections 
may therefore represent a new prospect for 
future anti-viral drug development.  
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FIGURE LEGENDS 
FIGURE 1. K
+
 channel inhibition impedes BUNV infection. (A) Representative western blots from 
BUNV infected A549 cells (24h, MOI 1) treated with the indicated K
+
 (TEA, KCl, K2S04), channel 
blockers. Lysates were resolved by SDS-PAGE and probed with sheep anti-BUNV N serum (n ≥ 3). 
Blots were reprobed for GAPDH as a loading control. (B) Densitometry of western blots from Figure 
1A from TEA (10mM), KCl (40mM), K2S04 (40mM), performed using ImageJ. Signals were 
normalised to BUNV infected, no-drug controls (n=3). Results are expressed as mean ± SE 
(*significant difference at the p≤ 0.05 level, NS= not-significant. (C) Cells plated onto coverslips 
were treated with TEA (10mM), KCl (20mM), K2S04 (20mM), and BUNV infected for 24 hours. 
Cells were fixed, permeabilsed and stained for BUNV-N (red) and DAPI (blue) using sheep anti-
BUNV-N serum and sheep Alexa-flour 594 antibodies. (D) The % of BUNV infected cells was 
assessed for each treatment from widefield images of BUNV-N stained cells (Grey bars). A minimum 
of 100 cells were counted. Results are expressed as mean ± SE (*significant difference at the p≤ 0.05 
level, NS= not-significant). A549 cells were treated as above and cell viability assessed via ATPlite 
assays (Black bars). Values are normalised to untreated controls. (E) A549 cells were infected ± 
10mM TEA and RNA were extracted at the indicated time points and subjected to primer extension 
analysis to quantify S segment anti-genomes and mRNAs using 33P end-labeled primer P-ext. The 
position at which P-ext annealed to BUNV specific positive sense RNAs is shown schematically. 
Resulting extension products were analyzed by denaturing 6% PAGE and visualized by 
autoradiography. 
 
FIGURE 2. K
+
 channel dependence is conserved across invertebrate and vertebrate cell types. (A) 
The indicated mammalian cell lines were treated with 40mM KCl or 10mM TEA and infected with 
BUNV (24h, MOI 1). BUNV-N production was assessed as in Fig 1A. (B) Vero cells were infected 
with 500 TCID
50
/ml BUNV in the presence of KCl or TEA for 5 days. Cells were fixed in 100% 
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ethanol and stained with 3% (w/v) crystal violet. Representative plates of three independent 
experiments are shown. (C) C6/36 Ae. albopictus cells were treated with the indicated concentrations 
of TEA and KCl and infected with BUNV in an identical procedure to A. Blots were reprobed for ß-
actin as a loading control.  
 
FIGURE 3. K
+
 channel dependence is bunyavirus specific.  (A) A549 cells were infected with HAZV 
(24 h, MOI 1) in the presence of the indicated concentrations of TEA. Lysates were resolved by SDS-
PAGE and probed with sheep anti-HAZV N serum. Blots are representative of two independent 
experiments. (ii) Cells were assessed for HAZV infection ± TEA (10mM) by staining fixed cells with 
sheep anti-HAZV serum and sheep Alexa flour 594 antibodies. Representative confocal images are 
shown. (iii) The % of HAZV infected cells was assessed ± TEA treatment from widefield images of 
HAZV-N stained cells. A minimum of 40 cells were counted. Results are expressed as mean ± SE 
(*significant difference at the p≤ 0.05 level, NS= not-significant). (B) Vero cells were infected with 
TCID50/ml SBV in the presence of KCl for 5 days. Cells were fixed in 100% ethanol and stained with 
3% (w/v) crystal Violet. Representative plates of three independent experiments are shown. (C)(i) 
A549 Cells were infected with hRSV (24 h, MOI 1) ± the indicated concentrations of TEA or 
ribavirin. Lysates were resolved by SDS-PAGE and probed with goat anti-hRSV antibodies (n ≥ 3). 
Blots were reprobed for GAPDH as a loading control. Lanes shown are from the same gel and 
representative of three independent experiments. (ii) A549 cells were infected with hRSV ± 10mM 
TEA and the % of hRSV infected cells assessed by immunofluorescence through staining with goat 
anti-hRSV antibodies and anti-goat Alexa fluor 594 antibodies. Representative confocal images are 
shown. (iii) Cells treated as in (ii) were assessed for the % of infected cells by FACs analysis. Results 
are the average of two independent experiments. Values are normalised to infected no-drug controls. 
Results are expressed as mean ± SE (*significant difference at the p≤ 0.05 level, NS= not-significant).  
 
FIGURE 4. K
+ 
channel activity is required at an early post-entry stage of BUNV infection. (A)(i) 
Cells were infected with BUNV in the presence of TEA (10mM), CPZ (30µM) and monensin (20µM) 
for 1 hour. Cells were washed with PBS + 0.5% Trypsin to remove cell attached viruses and cells 
incubated for a further 24 hours in media alone. BUNV-N expression as a marker of BUNV infection 
was assessed by western blot analysis (i), densitometry (ii) and immunofluorescence (B). (C) TEA 
was added at the indicated timepoints post-BUNV infection and BUNV-N expression assessed by 
western blot analysis 24 hours post-infection.  Unt (untreated) = no drug included during the 
timecourse, T=x indicates the inclusion of TEA throughout the time course of BUNV infection (n=3). 
(D) To assess BUNV RNA synthesis, BSRT7 cells were transfected with cDNA plasmids encoding 
BUNV S and L segment open reading frames (ORFs), and a model negative sense RNA segment that 
contained conserved BUNV 3’- and 5’- non-translated regions flanking the Renilla luciferase ORF. 
Cells were incubated with or without 10mM TEA, and 18 h post transfection cell lysates were 
analysed for luciferase activity (relative luminescence units [RLU] per second) as a measure of 
BUNV gene expression. The L ORF plasmid was omitted to act as a negative control to measure non-
BUNV mediated luciferase expression. Results were calculated relative to those for an untreated 
control. Error bars represent the standard errors of the means (SEM) of results from three independent 
experiments performed in duplicate. *, significant difference from the control value (P < 0.05); NS, 
no differences at a significance level of 0.05. 
 
FIGURE 5. BUNV hyperpolarises the membrane potential through K
+
 channel activation. (A) (i) 
A549 or (ii) C6/36 cells infected with BUNV (MOI 1), or treated with TEA (10mM)/quinidine 
(200µM) were exposed to the membrane potential sensitive fluorescent dye DiBAC4 (3) (20µM). 
Values represent 6 hpi/treatment and are normalised to untreated controls (n=3). Results are expressed 
as the mean fluorescence per cell ± SE of averaged widefield images (*significant difference from 
untreated cells at the p≤ 0.05 level). Data are representative of at least three independent experiments. 
(B) A549 cells infected with BUNV (MOI 1) or treated with NPPB (10 μM)/IAA-94 (100 μM) were 
exposed to 6-methoxy-quinolyl acetoethyl ester (MQAE). Fluorescent were acquired as in Fig 5A. 
Values represent 6 hpi/treatment and are normalised to untreated controls (n=3). Results are expressed 
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as the mean fluorescence per well ± SE of averaged widefield images (*significant difference from 
untreated cells at the p≤ 0.05 level). Data are representative of three independent experiments.  
 
FIGURE 6. Investigating the K
+
 channel families required during BUNV infection. (A) Table 
detailing the K
+ 
channel modulating compounds assessed for their effects on BUNV. (B) BUNV 
infected A549 cells (24h, MOI 1) were treated with the indicated concentrations of K
+
 channel 
modulators. Lysates were resolved by SDS-PAGE and probed with sheep anti-BUNV N serum. (C) 
Cells treated with Quinine (200µM), Quinidine (200µM), BaCl
2 
(2mM) and 4AP (1mM), Tram 34 
(3µM), Glibenclamide (20µM) and ifenprodil (30µm) during the 24 h infection period were fixed, 
permeabilised and stained for DAPI (blue) and BUNV-N (red) as in Fig.1. (D) The % of BUNV 
infected cells was assessed for each treatment from widefield images of BUNV-N stained cells (Grey 
bars). A minimum of 100 cells were counted from at least three independent experiments. ATPlite 
assays were performed for each drug treatment  for 24h and normalised to no-drug controls to assess 
cell viability (Black bars). Results are expressed as mean ± SE (*significant difference at the p≤ 0.05 
level).  (E) TCID
50
/ml BUNV assays were performed for selected  drug treatments as in Figure 2D. 
Representative plates of three independent experiments are shown. (F) Quinidine was added at the 
indicated timepoints post-BUNV infection and BUNV-N expression assessed by western Blot 
analysis 24 hours post-infection. Unt= no drug included during the time course, T=0 indicates the 
inclusion of quinidine throughout the timecourse of BUNV infection (n=3). 
 
FIGURE 7. Two-pore potassium channel blockers inhibit BUNV infection. (A)(i) RT-PCR 
demonstrates that several K2P channels are expressed in A549 cells. Templates for the reactions were 
derived from uninfected A549 cells. Negative control reactions lacked template during amplification. 
Identical results were obtained with at least 2 additional preparations of RNA. GAPDH was included 
as a control. (ii) Indicated K2P channels were assessed for expression in A549 cells through 
immunofluorescent analysis. Representative confocal images are shown. (B) Table detailing the K2P 
modulating compounds investigated during the study. (C) BUNV infected A549 cells (24h, MOI 1) 
were treated with a range of compounds shown previously to inhibit members of the K
2P 
channel 
family
.
 Lysates were resolved by SDS-PAGE and probed with sheep anti-BUNV-N serum. (D)(i) 
Cells treated with RuR (50µM), Spermine (500µM), Bupavacaine (150µM), Haloperidol (20µM) and 
Fluoxetine (30µM) were infected as in (B) and fixed, permeabilsed and stained for DAPI (blue) and 
BUNV-N (red). (ii) The % of BUNV infected cells was assessed for each treatment from widefield 
images of BUNV-N stained cells (Grey bars). A minimum of 100 cells were counted from three 
independent experiments. ATPlite assays were performed for each drug treatment and normalised to 
untreated controls to assess cell viability (Black bars). Results are expressed as mean ± SE 
(*significant difference at the p≤ 0.05 level).  
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